Status: current, Defined. Date: 31-Oct 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4644003019 | Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
4644004013 | Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial | Is a | Clavulanic acid and ticarcillin only product in parenteral dose form | true | Inferred relationship | Some | ||
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial | Has manufactured dose form | Powder for solution for injection | true | Inferred relationship | Some | ||
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial | Has unit of presentation | Vial | true | Inferred relationship | Some | ||
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Some | ||
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial | Has precise active ingredient | Ticarcillin sodium | true | Inferred relationship | Some | 1 | |
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial | Has BoSS | Ticarcillin | true | Inferred relationship | Some | 1 | |
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial | Has presentation strength numerator unit | g | true | Inferred relationship | Some | 1 | |
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial | Has presentation strength denominator unit | Vial | true | Inferred relationship | Some | 1 | |
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial | Has precise active ingredient | Clavulanate potassium | true | Inferred relationship | Some | 2 | |
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial | Has BoSS | Clavulanic acid | true | Inferred relationship | Some | 2 | |
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial | Has presentation strength denominator unit | Vial | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets